A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...
Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Effective strategies are needed to facilitate the prompt diagnosis and treatment of tuberculosis in countries with a high burden of the disease. We conducted a cluster-randomized trial in which ...
The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...
Variables that impact decisions to initiate therapy for solid tumor cancers versus wait for results of genomic profiling assays. Bruce Feinberg, DO: I asked Kenna. You can't talk for her. Kenna R.
We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...
Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...
The COVID-19 pandemic continues to rage, with more than five million deaths worldwide. The urgent, global nature of the pandemic has led to great innovation with novel vaccines and diagnostics, ...
ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ -- Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results